CAD & Atherosclerosis
News
Stopping aspirin after bleeding ulcer raises CV death rate sixfold
Major Finding: The combined rate of death or acute CV events during the first 6 months of follow-up was more than sixfold higher in patients who...
News
FDA issues CV safety update for smoking cessation drug
News
Study connects aspirin 'resistance' to enteric coating
Major Finding: "Resistance" to a 325-mg dose of enteric-coated aspirin was as high as 49%, compared with 0% after the same patients took immediate...
News
Bariatric surgery cut vascular events in diabetes
Major Finding: Bariatric surgery was linked to a 64% decrease in macro- and microvascular events compared with no surgery in obese type 2 diabetes...
Conference Coverage
Studies put kibosh on statins for breast cancer prevention
Conference Coverage
Statins' Diabetogenic Impact Influenced by Underlying Risks
Major Finding: High-dose atorvastatin raised the relative risk for incident diabetes 24% in patients with two or more diabetes risk factors.Data...
News
PCSK9 Antibodies Safely Cut LDL in Phase II
Major Finding: Patients on the largest Amgen 145 dosage had an average 66% reduction in their LDL cholesterol, and 90% reached their goal LDL...
Conference Coverage
Polypill Improves Cardiovascular Health in UMPIRE
Major Finding: A polypill – a fixed-dose combination of four cardiovascular medications – substantially improved patient adherence and other end...
News
Ranbaxy Recalls Atorvastatin
Conference Coverage
Hodgkin's Lymphoma Radiation Linked to Cardiovascular Disease
Major Finding: A minimum of 5 years after undergoing radiation therapy for Hodgkin’s lymphoma, 26% of patients had occult cardiovascular disease....
Conference Coverage
Dalcetrapib Boosts HDL Without Benefiting Patients
Major Finding: After a median 31 months, patients treated with dalcetrapib or placebo showed no significant difference in primary end point events...